Western Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Western Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,968	Closed	-$13K	–	820
2022 Q3	$13K	Hold	10,968	–	–	﹤0.01%	806
2022 Q2	$20K	Hold	10,968	–	–	﹤0.01%	781
2022 Q1	$22K	Buy	+10,968	New	+$21.5K	﹤0.01%	818

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Western Wealth Management's CLVS Position: Q4 2022 in Review

Western Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 10,968 shares — an estimated $13K sold.

Western Wealth Management first reported a position in CLVS in Q1 2022 and held it in 3 quarters. The position peaked at $22K in Q1 2022. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

Western Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
Western Wealth Management sold 10,968 Clovis Oncology, Inc. shares in Q4 2022, an estimated $13K.
Western Wealth Management first reported a position in Clovis Oncology, Inc. in Q1 2022 and held it in 3 quarters.
Western Wealth Management's Clovis Oncology, Inc. position peaked at $22K in Q1 2022.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Western Wealth Management's 13F filing for Q4 2022, filed 3 Feb 2023.